TekCyte is a world leader in the development and manufacturing of advanced coatings for medical device and biomedical applications.
We use world-leading surface technologies with best-in-class manufacturing to create implantable medical devices that influence the behaviour of living tissue. As experts in coatings for medical device and biomedical applications, our high-quality coatings are commercially scalable to meet the needs of medical device manufacturers.
Based in Adelaide, Australia, TekCyte emerged from the Cooperative Research Centre (CRC) for Cell Therapy Manufacturing, established July 2013.
In 2018 TekCyte established itself as an independent company. Now a public unlisted company, TekCyte is led by CEO Dr Tony Simula and a Board of Directors who have each founded a successful biotech company. Tony brings 25+ years’ experience leading biomedical product commercialisation and is passionate about commercialising great technologies that will have a significant impact on how we treat disease and manage medical conditions, to improve the quality of life for patients.
The team of scientists at TekCyte possess an extensive range of skills and experience with specialist knowledge and education in the areas of biomaterial science and microbiology.
TekCyte has a proven history of creating and delivering solutions for the medtech industry. They are a trusted supply partner for medical device companies world-wide.
Select your desired option below to share a direct link to this page.
Your friends or family will thank you later.